Trials / Conditions / Nonarteritic Anterior Ischemic Optic Neuropathy
Nonarteritic Anterior Ischemic Optic Neuropathy
6 registered clinical trials studyying Nonarteritic Anterior Ischemic Optic Neuropathy — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications NCT07240649 | Jay C. Buckey Jr. | Phase 4 |
| Completed | Platelet-Rich Plasma for Acute Nonarteritic Anterior Ischemic Optic Neuropathy: A Prospective Randomized Contr NCT07330713 | Uludag University | N/A |
| Terminated | Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropath NCT03547206 | Regenera Pharma Ltd | Phase 2 |
| Completed | A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhi NCT01131104 | Eli Lilly and Company | — |
| Completed | Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy NCT00561834 | University of Colorado, Denver | Phase 1 |
| Completed | Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic O NCT00432393 | Shahid Beheshti University of Medical Sciences | Phase 4 |